Key result
Quantitative cardiac CT perfusion shows ~40% lower MBF in territories with obstructive stenosis.
Why the study?
The study evaluated an advanced, physiologically inspired cardiac CT perfusion software to distinguish myocardial ischemia caused by obstructive coronary disease from microvascular disease.
Can automated quantitative cardiac CT perfusion distinguish ischemia due to obstructive coronary lesions from microvascular disease in patients with suspected CAD?
Observational (n=104)
Single-blind
No
Can automated quantitative cardiac CT perfusion distinguish ischemia due to obstructive coronary lesions from microvascular disease in patients with suspected CAD?
Automated quantitative cardiac CT perfusion can effectively differentiate between ischemia caused by obstructive coronary artery disease and microvascular disease, highlighting a high prevalence of microvascular disease in diabetic patients.
May aid differentiation of obstructive from microvascular ischemia on CT perfusion; hypothesis-generating and should not yet change practice.
Objective Use our advanced, physiologically inspired cardiac CT perfusion (CCTP) software to distinguish ischemia due to obstructive disease vs. microvascular disease (MVD). Background Previously validated advanced CCTP methods were used. We interpreted results to identify flow-limiting stenosis [i.e., obstructive-lesion & low myocardial blood flow (MBF)] vs. microvascular disease (i.e., no-obstructive-lesion & low-MBF). Methods We retrospectively evaluated 104 patients with suspected CAD, including 18 with diabetes, who underwent CCTA + CCTP. Whole heart and territorial MBF was assessed using our automated pipeline for CCTP analysis that included beam hardening correction; temporal scan registration; automated segmentation; fast, accurate, robust MBF estimation; and visualization. Stenosis severity was scored using the CCTA coronary-artery-disease-reporting-and-data-system (CAD-RADS), with obstructive stenosis deemed as CAD-RADS ≥ 3. Results We established a threshold MBF (MBF = 200-mL/min-100 g) for normal perfusion. In patients with CAD-RADS ≥ 3 (obstructive disease), 28/37(76%) patients showed ischemia in the corresponding territory. On a per-vessel basis ( n = 256), MBF showed a significant difference between territories with and without obstructive stenosis (165 ± 61 mL/min−100 g vs. 274 ± 62 mL/min−100 g, p < 0.05). A significant negative rank correlation ( ρ = −0.53, p < 0.05) between territory MBF and CAD-RADS was seen. Two patients with obstructive disease had normal perfusion, suggesting collaterals and/or hemodynamically insignificant stenosis. Among diabetics, 10 of 18 (56%) demonstrated diffuse ischemia consistent with MVD. Among non-diabetics, only 6% had MVD. Sex-specific prevalence of MVD was 21%/24% (M/F). Conclusion CCTA in conjunction with a new automated quantitative CCTP approach can determine the distinction of ischemia due to obstructive lesions vs. MVD.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2025) conducted an observational in Suspected coronary artery disease (n=104). Quantitative cardiac CT perfusion (CCTP) vs. Territories without obstructive stenosis was evaluated on Myocardial blood flow (MBF) on a per-vessel basis (p=<0.05). Quantitative cardiac CT perfusion demonstrated significantly lower myocardial blood flow in territories with obstructive stenosis compared to those without (165 vs 274 mL/min-100 g).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: